Kuželová et al. [47] found that in a cohort of 63 AML patients with NPM1mut, compared with 94 patients with NPM1WT, there was a significant decrease in HLA-B*07, B*18, and B*40 expression. The gene discussed is HLA-B; the disease is acute myeloid leukemia.